Genetic Scores Might Help Determine Prostate Cancer Risk
Can genetic scores provide an objective measure of prostate cancer risk and aid screening decisions?
Can genetic scores provide an objective measure of prostate cancer risk and aid screening decisions?
While co-infection with more than one respiratory virus was especially a problem this fall and winter, it has happened before, especially in an environment where SARS-CoV-2 is circulating.
Even after years of the COVID-19 pandemic, data remains somewhat limited on the safety profile of SARS-CoV-2 vaccine in patients taking immunosuppressive medications.
Despite misconceptions that prior COVID-19 infections can keep patients from having severe cases in the future, a new study suggests that recurrent cases pile on the risk of adverse health conditions in multiple organ systems.
Much of the focus during the COVID-19 pandemic has been on the infection itself, as well as persistent symptoms. But many other aspects of healthcare underwent changes of SARS-CoV-2 and the efforts to combat it.